Sars-cov-2 vaccines induce durable neutralizing antibodies in infant rhesus macaques

Authors

Carolina Garrido, Duke Human Vaccine Institute
Alan D. Curtis, University of North Carolina at Chapel Hill
Hongmei Gao, Duke Human Vaccine Institute
David Montefiori, Duke Human Vaccine Institute
Mark Tomai, 3M Corporate Research Materials Laboratory
Pamela A. Kozlowski, LSUHSC New OrleansFollow
Lisa C. Lindesmith, University of North Carolina at Chapel Hill
Ralph Baric, University of North Carolina at Chapel Hill
Barney S. Graham, National Institute of Allergy and Infectious Diseases
Kizzmekia Corbett, National Institute of Allergy and Infectious Diseases
Darin Edwards, Moderna, Inc
Andrea Carfi, Moderna, Inc
Koen K. Van Rompay, University of California Davis
Kristina De Paris, University of North Carolina at Chapel Hill
Sallie Permar, Weill Cornell Medicine

Document Type

Article

Publication Date

3-1-2021

Publication Title

Topics in Antiviral Medicine

Volume

29(1)

Comments

2021 Conference on Retroviruses and Opportunistic Infections

Recommended Citation

Garrido, Carolina; Curtis, Alan D.; Gao, Hongmei; Montefiori, David; Tomai, Mark; Kozlowski, Pamela A.; Lindesmith, Lisa C.; Baric, Ralph; Graham, Barney S.; Corbett, Kizzmekia; Edwards, Darin; Carfi, Andrea; Van Rompay, Koen K.; De Paris, Kristina; and Permar, Sallie, "Sars-cov-2 vaccines induce durable neutralizing antibodies in infant rhesus macaques" (2021). School of Medicine Faculty Publications. 1233.
https://digitalscholar.lsuhsc.edu/som_facpubs/1233